![Oliver von Stein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Oliver von Stein
Algemeen Directeur bij
Berlin Cures Holding AG
Profiel
Oliver von Stein currently works at Berlin Cures Holding AG, as Chief Executive Officer & Director from 2024 and Berlin Cures GmbH, as Chief Executive Officer.
Dr. von Stein also formerly worked at Silence Therapeutics Plc, as Operations Director from 2014 to 2015, MediGene AG, as Project Leader, and Flerie AB, as Chief Scientific Officer.
Dr. von Stein received his doctorate degree from Karlsruher Institut für Technologie.
Actieve functies van Oliver von Stein
| Bedrijven | Functie | Begin |
|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Algemeen Directeur | 15-06-2023 |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Algemeen Directeur | - |
Eerdere bekende functies van Oliver von Stein
| Bedrijven | Functie | Einde |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Operationeel Directeur | 01-08-2015 |
| MEDIGENE AG | Corporate Officer/Principal | - |
| FLERIE INVEST AB | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Oliver von Stein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Karlsruher Institut für Technologie
 Karlsruher Institut für Technologie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Develops drug to neutralize auto antibodies | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Health Technology |
